1
|
Wang N, Chen C, Cheng Y, Fu Y, Zhong Z, Yang Y, Lv L, Chen H, Huang J, Duan Y. Hypoxia drives hematopoiesis with the enhancement of T lineage through eliciting arterial specification of hematopoietic endothelial progenitors from hESC. Stem Cell Res Ther 2022; 13:282. [PMID: 35765115 PMCID: PMC9241298 DOI: 10.1186/s13287-022-02967-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Accepted: 06/19/2022] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND Hematopoietic stem cells are able to self-renew and differentiate into all blood cell lineages. Hematopoietic stem cell transplantation is a mainstay of life-saving therapy for hematopoietic malignancies and hypoproliferative disorders. In vitro hematopoietic differentiation of human pluripotent stem cells (hPSCs) is a promising approach for modeling hematopoietic development and cell replacement therapies. Although using hPSCs to derive hematopoietic progenitor cells has achieved some successes in the past, differentiation from hPSCs to produce all hematopoietic cells which can provide robust long-term multilineage engraftment is still very difficult. Here, we reported a novel culture system for hematopoietic differentiation from human embryonic stem cells (hESCs) with optimal cytokines combinations under hypoxia condition. METHODS In vitro production of T lineage hematopoietic stem/progenitor cells from hESCs by using hypoxia differentiation system, the effects and the potential mechanism of hypoxia promoting T lineage hematopoiesis were investigated by RT-qPCR validation, cell cycle assay and flow cytometry analysis. RESULTS Using our differentiation system, almost 80% CD45+ cells generated from hESCs were hematopoietic cells and particularly could be further induced into CD3+TCRαβ+ T cells in vitro. We detected more CD34+CD144+ hematopoietic endothelial progenitors (HEPs) induced from hESCs than those in normoxia conditions, and the early HEPs-related gene DLL4 was upregulated by enhancing the hypoxia signaling via potential HIF-1α/NOTCH1/DLL4 axis to enhance arterial feature, thus drove T lineage during the hematopoiesis. Strikingly, hematopoietic cells generated in our system exhibited the potential for all multilineage reconstruction including lymphoid, myeloid and erythroid lineages in vivo by transplantation assay. CONCLUSION Our results demonstrated that hypoxia plays an important role in T lineage hematopoiesis by promoting the expression of arterial endothelial gene DLL4 and upregulation of NOTCH1 through the activation of the HIF-1α signaling pathway. These results provide a significant approach for in vitro and in vivo production of fully functional hematopoietic stem/progenitor cells from hESCs.
Collapse
Affiliation(s)
- Ning Wang
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 510006, People's Republic of China
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences and School of Medicine, Higher Education Mega Center, South China University of Technology, No.382 Waihuan East Road, Suite 406, Guangzhou, 510006, People's Republic of China
| | - Chuxin Chen
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, People's Republic of China
| | - Yang Cheng
- Department of Gynaecology and Obstetrics, Guangzhou First People's Hospital, Guangzhou, 510180, People's Republic of China
| | - Yingjie Fu
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences and School of Medicine, Higher Education Mega Center, South China University of Technology, No.382 Waihuan East Road, Suite 406, Guangzhou, 510006, People's Republic of China
| | - Zhiyong Zhong
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 510006, People's Republic of China
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences and School of Medicine, Higher Education Mega Center, South China University of Technology, No.382 Waihuan East Road, Suite 406, Guangzhou, 510006, People's Republic of China
| | - Yu Yang
- Department of Gynaecology and Obstetrics, Guangzhou First People's Hospital, Guangzhou, 510180, People's Republic of China
| | - Ling Lv
- Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guang Zhou Road, Nanjing, 210029, People's Republic of China.
| | - Honglin Chen
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences and School of Medicine, Higher Education Mega Center, South China University of Technology, No.382 Waihuan East Road, Suite 406, Guangzhou, 510006, People's Republic of China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, People's Republic of China.
- Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, 510006, People's Republic of China.
- Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Guangzhou, 510006, People's Republic of China.
| | - Jian Huang
- Coriell Institute for Medical Research, Camden, NJ, USA.
- Cooper Medical School of Rowan University, Camden, NJ, USA.
| | - Yuyou Duan
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences and School of Medicine, Higher Education Mega Center, South China University of Technology, No.382 Waihuan East Road, Suite 406, Guangzhou, 510006, People's Republic of China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, People's Republic of China.
- Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, 510006, People's Republic of China.
- Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Guangzhou, 510006, People's Republic of China.
| |
Collapse
|
2
|
You X, He Y, Dai B, He J, Zhu F. Characterization of the novel HLA-C*01:02:56 and HLA-C*01:02:57 alleles by sequencing-based typing. HLA 2021; 97:557-560. [PMID: 33624426 DOI: 10.1111/tan.14236] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 01/18/2023]
Abstract
Compared with HLA-C*01:02:01:01, the alleles HLA-C*01:02:56 and HLA-C*01:02:57 each show one synonymous nucleotide substitution.
Collapse
Affiliation(s)
- Xuan You
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Yanmin He
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Bing Dai
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Ji He
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Faming Zhu
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| |
Collapse
|
3
|
Wang W, Wang F, You X, He J, Zhu F. Identification of the novel HLA-C*12:220 allele in a Chinese individual. HLA 2019; 94:80-81. [PMID: 30953389 DOI: 10.1111/tan.13548] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Revised: 04/03/2019] [Accepted: 04/04/2019] [Indexed: 12/12/2022]
Abstract
The new allele HLA-C*12:220 differs from HLA-C*12:03:01:01 by one nucleotide substitution in exon 7.
Collapse
Affiliation(s)
- Wei Wang
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Fang Wang
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Xuan You
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Ji He
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| | - Faming Zhu
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China
| |
Collapse
|
4
|
Zhao S, Wang W, Zhang W, He J, Zhu F. Identification of the novel HLA-B*40:357 allele by polymerase chain reaction sequence-based typing. HLA 2019; 94:68-70. [PMID: 30868741 DOI: 10.1111/tan.13519] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Revised: 03/10/2019] [Accepted: 03/11/2019] [Indexed: 11/25/2022]
Abstract
HLA-B*40:357 shows a substitution C to G at position 263 when compared to HLA-B*40:01:01.
Collapse
Affiliation(s)
- Shuoxian Zhao
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, China.,Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, Zhejiang, China
| | - Wei Wang
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, China.,Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, Zhejiang, China
| | - Wei Zhang
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, China.,Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, Zhejiang, China
| | - Ji He
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, China.,Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, Zhejiang, China
| | - Faming Zhu
- HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, China.,Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, Zhejiang, China
| |
Collapse
|
5
|
Wang W, Wang F, Zhang W, He J, Zhu F. Characterization of the novel
HLA‐C*08:154
allele by sequencing‐based typing. HLA 2019; 93:238-240. [DOI: 10.1111/tan.13487] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 02/07/2019] [Accepted: 02/08/2019] [Indexed: 11/30/2022]
Affiliation(s)
- Wei Wang
- HLA typing laboratoryBlood Center of Zhejiang Province Hangzhou, Zhejiang China
- HLA typing laboratoryKey Laboratory of Blood Safety Research, Zhejiang Province Hangzhou, Zhejiang China
| | - Fang Wang
- HLA typing laboratoryBlood Center of Zhejiang Province Hangzhou, Zhejiang China
- HLA typing laboratoryKey Laboratory of Blood Safety Research, Zhejiang Province Hangzhou, Zhejiang China
| | - Wei Zhang
- HLA typing laboratoryBlood Center of Zhejiang Province Hangzhou, Zhejiang China
- HLA typing laboratoryKey Laboratory of Blood Safety Research, Zhejiang Province Hangzhou, Zhejiang China
| | - Ji He
- HLA typing laboratoryBlood Center of Zhejiang Province Hangzhou, Zhejiang China
- HLA typing laboratoryKey Laboratory of Blood Safety Research, Zhejiang Province Hangzhou, Zhejiang China
| | - Faming Zhu
- HLA typing laboratoryBlood Center of Zhejiang Province Hangzhou, Zhejiang China
- HLA typing laboratoryKey Laboratory of Blood Safety Research, Zhejiang Province Hangzhou, Zhejiang China
| |
Collapse
|
6
|
Dong L, Wang F, Zhang W, He J, Faming Z. Characterization of the novel HLA-B*51:228 allele in a Chinese individual. HLA 2019; 93:120-122. [PMID: 30629812 DOI: 10.1111/tan.13465] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Revised: 01/06/2019] [Accepted: 01/07/2019] [Indexed: 11/26/2022]
Abstract
HLA-B*51:228 differs from HLA-B*51:01:01:01 by a single-nucleotide substitution at codon 151 in exon 3.
Collapse
Affiliation(s)
- Lina Dong
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| | - Fang Wang
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| | - Wei Zhang
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| | - Ji He
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| | - Zhu Faming
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| |
Collapse
|